Related Experiment Video
Updated: Mar 13, 2026

09:23
Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex
Published on: June 30, 2019
12.7K
Non-Human Primate Models of Tuberculosis
Juliet C Peña1, Wen-Zhe Ho1,2
1Department of Pathology and Laboratory Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA 19140.
Microbiology Spectrum
|October 12, 2016
Summary
Non-human primate models, specifically macaques, closely mimic human tuberculosis (TB). These animals are crucial for understanding TB pathogenesis and testing new drugs and vaccines against Mycobacterium tuberculosis.
Area of Science:
- Primate models in infectious disease research
- Tuberculosis pathogenesis and immunology
- Preclinical drug and vaccine development
Background:
- Tuberculosis (TB) remains a global health challenge.
- Effective animal models are essential for TB research.
- Non-human primates offer significant physiological and anatomical parallels to humans.
Purpose of the Study:
- To review the utility of macaque models in tuberculosis research.
- To highlight how macaques advance understanding of Mycobacterium tuberculosis infection.
- To showcase the role of macaques in preclinical TB therapeutics evaluation.
Main Methods:
- Review of major published studies utilizing rhesus and cynomolgus macaques.
- Analysis of macaque susceptibility to Mycobacterium tuberculosis.
- Examination of clinical and pathological manifestations in macaque TB models.
Main Results:
- Macaques exhibit high susceptibility to Mycobacterium tuberculosis.
- These models replicate the full spectrum of human TB manifestations.
- Extensive use of macaques in pathogenesis studies and preclinical testing.
Conclusions:
- Rhesus and cynomolgus macaques are invaluable models for TB research.
- These primate models significantly contribute to global TB control efforts.
- Continued use of macaques will drive advancements in TB diagnostics, treatments, and vaccines.
Related Concept Videos
Pulmonary Tuberculosis II
1.9K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
Pulmonary Tuberculosis I
1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K

